SEC Form 4 · accession 0001415889-18-000754
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Frank L Jaksch Jr.
Officer — CEO · Director
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | P | 5,500 | $3.61 | A | 207,057 | D | |
| Common Stock | May 16, 2018 | P | 4,300 | $3.56 | A | 211,357 | D | |
| Common Stock | holding | — | — | — | 2,075,052 | I | By Black Sheep, FLP |
Table II — derivative securities
No Table II lines on this filing.